Bitcoin has fallen more than 54% from its October 2025 peak, currently trading near $58,650. This represents the largest and longest decline since 2022, triggered by a historic $19.37 billion single-day liquidation. The downturn signals a shift in market sentiment toward higher volatility and risk aversion, with investors adopting more defensive strategies. Upcoming days are critical as Bitcoin's price hovers near key levels around $56,000, with macroeconomic factors and crypto market events expected to influence its trajectory.
Dimensional Fund Advisors Ltd disclosed a sale of 730,460 ordinary shares of Beazley PLC, reducing its holding to 0.89% as of June 30, 2026. This transaction reflects a partial exit from their investment in Beazley PLC. The sale price per share was a...
The global pyrometer market, valued at $544.55 million in 2025, is projected to reach $1.15 billion by 2035, growing at a CAGR of 7.57%. This growth is fueled by rising industrial automation and expansion in semiconductor manufacturing, which increas...
Abeona Therapeutics announced it granted restricted stock awards to five new non-executive employees as an inducement to join the company, totaling up to 9,000 shares. These shares will vest over three years, contingent on continued employment. This ...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The lawsuits allege these companies made false or misleading statements affe...
Step Pharma has appointed Neil J. Gallagher, MD, PhD, as a Non-Executive Director to strengthen its board as it advances dencatistat, a first-in-class CTPS1 inhibitor targeting essential thrombocythaemia, lymphoma, and solid tumours. Gallagher brings...
